Eye-Tracking tech could spot macular degeneration faster
NCT ID NCT06518512
First seen Jan 11, 2026 · Last updated Jun 19, 2026 · Updated 28 times
Summary
This study tests a device called AVIGA that tracks eye movements to detect vision problems in people with wet age-related macular degeneration (AMD). Researchers will compare the device's results with standard eye exams to see if it can reliably spot disease activity. The goal is to develop a quick, automated way to monitor AMD over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tan Tock Seng Hospital
Singapore, 308433, Singapore
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system
What this could lead to
If successful, this could lead to a simple, automated eye-tracking test to detect and monitor wet age-related macular degeneration without the need for complex equipment.
What could go wrong
This is an early-stage study with 128 participants, so results may not apply to everyone. The device is not yet proven to replace standard tests.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.